Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
This report elaborates on the current development of the Nanoparticles in Biotechnology and Pharmaceuticals industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer
Merck
Amgen
Biogen
Novartis
Pacira Pharmaceuticals
GE Healthcare
Shire
Gilead
AMAG Pharmaceuticals
Celgene
Bausch & Lomb
Roche
By Type:
Nanoshells
Fullerenes
Quantum dots
Superparamagnetic nanoparticles
Liposomes
Liquid Crystals
By Application:
Biotechnology
Pharmaceutical
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Nanoparticles in Biotechnology and Pharmaceuticals Market Overview 2018-2029
-
1.1 China Nanoparticles in Biotechnology and Pharmaceuticals Industry Development Overview
-
1.2 China Nanoparticles in Biotechnology and Pharmaceuticals Industry Development History
-
1.3 China Nanoparticles in Biotechnology and Pharmaceuticals Industry Market Size (2018-2029)
-
1.4 China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis by Type from Production Side
-
1.4.1 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Nanoshells (2018-2029)
-
1.4.2 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Fullerenes (2018-2029)
-
1.4.3 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Quantum dots (2018-2029)
-
1.4.4 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Superparamagnetic nanoparticles (2018-2029)
-
1.4.5 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Liposomes (2018-2029)
-
1.4.6 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Liquid Crystals (2018-2029)
-
1.5 China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis by Application from Consumption End
-
1.5.1 China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume, Sales Value and Growth Rate of Biotechnology (2018-2029)
-
1.5.2 China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume, Sales Value and Growth Rate of Pharmaceutical (2018-2029)
-
1.6 China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis by Region
-
1.6.1 North China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
Chapter 2 China Nanoparticles in Biotechnology and Pharmaceuticals Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Nanoparticles in Biotechnology and Pharmaceuticals Market Status and Competition at home and abroad in 2023
-
2.2.2 China Nanoparticles in Biotechnology and Pharmaceuticals Market Status and Competition Analysis in 2023
-
2.2.3 China Nanoparticles in Biotechnology and Pharmaceuticals Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Nanoparticles in Biotechnology and Pharmaceuticals Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Nanoparticles in Biotechnology and Pharmaceuticals Industry Development
Chapter 3 Nanoparticles in Biotechnology and PharmaceuticalsIndustry Chain Analysis
-
3.1 Nanoparticles in Biotechnology and Pharmaceuticals Industry Chain
-
3.2 Nanoparticles in Biotechnology and Pharmaceuticals Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Nanoparticles in Biotechnology and Pharmaceuticals Market
-
3.3 Nanoparticles in Biotechnology and Pharmaceuticals Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Nanoparticles in Biotechnology and Pharmaceuticals Market
Chapter 4 China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
4.1 China Nanoparticles in Biotechnology and Pharmaceuticals Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Nanoparticles in Biotechnology and Pharmaceuticals Total Production Volume and Growth Rate from Production Side
-
4.5 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate, by Type
-
4.5.1 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Nanoshells
-
4.5.2 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Fullerenes
-
4.5.3 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Quantum dots
-
4.5.4 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Superparamagnetic nanoparticles
-
4.5.5 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Liposomes
-
4.5.6 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Liquid Crystals
Chapter 5 China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Nanoparticles in Biotechnology and Pharmaceuticals Total Market Size and Growth Rate from Consumption End
-
5.5 China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate, by Application
-
5.5.1 China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate of Biotechnology
-
5.5.2 China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate of Pharmaceutical
Chapter 6 China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Region
-
6.1 China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Production Value, by Region
-
6.2 China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume and Sales Value, by Region
Chapter 7 North China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
-
7.1 North China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
7.2 North China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
Chapter 8 Central China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
-
8.1 Central China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
8.2 Central China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
Chapter 9 South China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
-
9.1 South China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
9.2 South China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
Chapter 10 East China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
-
10.1 East China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
10.2 East China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
Chapter 11 Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
-
11.1 Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
11.2 Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
Chapter 12 Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
-
12.1 Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
12.2 Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
Chapter 13 Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
-
13.1 Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Type
-
13.2 Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer
-
14.1.1 Pfizer Company Profile
-
14.1.2 Pfizer Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck
-
14.2.1 Merck Company Profile
-
14.2.2 Merck Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Amgen
-
14.3.1 Amgen Company Profile
-
14.3.2 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Biogen
-
14.4.1 Biogen Company Profile
-
14.4.2 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Novartis
-
14.5.1 Novartis Company Profile
-
14.5.2 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Pacira Pharmaceuticals
-
14.6.1 Pacira Pharmaceuticals Company Profile
-
14.6.2 Pacira Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 GE Healthcare
-
14.7.1 GE Healthcare Company Profile
-
14.7.2 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Shire
-
14.8.1 Shire Company Profile
-
14.8.2 Shire Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Gilead
-
14.9.1 Gilead Company Profile
-
14.9.2 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 AMAG Pharmaceuticals
-
14.10.1 AMAG Pharmaceuticals Company Profile
-
14.10.2 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Celgene
-
14.11.1 Celgene Company Profile
-
14.11.2 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Bausch & Lomb
-
14.12.1 Bausch & Lomb Company Profile
-
14.12.2 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Roche
-
14.13.1 Roche Company Profile
-
14.13.2 Roche Nanoparticles in Biotechnology and Pharmaceuticals Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Nanoparticles in Biotechnology and Pharmaceuticals Industry Research Conclusions
-
15.2 Nanoparticles in Biotechnology and Pharmaceuticals Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Industry Market Size (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Nanoshells (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Fullerenes (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Quantum dots (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Superparamagnetic nanoparticles (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Liposomes (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume, Production Value and Growth Rate of Liquid Crystals (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume, Sales Value and Growth Rate of Biotechnology (2018-2029)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume, Sales Value and Growth Rate of Pharmaceutical (2018-2029)
-
Figure North China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
Figure Central China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
Figure South China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
Figure East China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate from 2018-2029
-
Figure Nanoparticles in Biotechnology and Pharmaceuticals Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Market Share by Type in 2018
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Market Share by Type in 2023
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Nanoshells (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Fullerenes (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Quantum dots (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Superparamagnetic nanoparticles (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Liposomes (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume and Growth Rate of Liquid Crystals (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Market Share by Application in 2018
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Market Share by Application in 2023
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Total Market Size and Growth Rate from Consumption End
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate of Biotechnology (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Market Size and Growth Rate of Pharmaceutical (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Region (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Region (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Region (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Production Value by Region (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Production Value Share by Region (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Production Value Share by Region (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Region (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Region (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Region (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Sales Value by Region (2018-2023)
-
Table China Nanoparticles in Biotechnology and Pharmaceuticals Sales Value Share by Region (2018-2023)
-
Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales Value Share by Region (2018-2023)
-
Table North China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Type (2018-2023)
-
Table North China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Figure North China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Table North China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Application (2018-2023)
-
Table North China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Figure North China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Table Central China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Type (2018-2023)
-
Table Central China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Figure Central China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Table Central China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Application (2018-2023)
-
Table Central China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Figure Central China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Table South China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Type (2018-2023)
-
Table South China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Figure South China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Table South China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Application (2018-2023)
-
Table South China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Figure South China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Table East China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Type (2018-2023)
-
Table East China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Figure East China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Table East China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Application (2018-2023)
-
Table East China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Figure East China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Table Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Type (2018-2023)
-
Table Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Figure Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Table Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Application (2018-2023)
-
Table Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Table Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Type (2018-2023)
-
Table Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Figure Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Table Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Application (2018-2023)
-
Table Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Table Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume by Type (2018-2023)
-
Table Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Figure Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Production Volume Share by Type (2018-2023)
-
Table Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume by Application (2018-2023)
-
Table Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Nanoparticles in Biotechnology and Pharmaceuticals Sales Volume Share by Application (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Biogen Company Profile
-
Table Biogen Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Pacira Pharmaceuticals Company Profile
-
Table Pacira Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table GE Healthcare Company Profile
-
Table GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Shire Company Profile
-
Table Shire Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Gilead Company Profile
-
Table Gilead Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table AMAG Pharmaceuticals Company Profile
-
Table AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Bausch & Lomb Company Profile
-
Table Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Nanoparticles in Biotechnology and Pharmaceuticals Revenue, Price and Gross (2018-2023)
-
